» Articles » PMID: 25336060

Shedding of Norovirus in Symptomatic and Asymptomatic Infections

Overview
Date 2014 Oct 23
PMID 25336060
Citations 108
Authors
Affiliations
Soon will be listed here.
Abstract

Norovirus is the most frequent cause of acute infectious gastroenteritis and it is difficult to control in crowded environments like hospitals and nursing homes. Transmission depends on oral intake of virus deposited in the environment by infectious subjects. Data from volunteer studies indicate that virus concentrations in stool are highly variable, but systematic studies of the time-course of shedding and its individual variation are lacking. This paper quantifies norovirus shedding in a large population of 102 subjects, including asymptomatic shedders, and uses a longitudinal model to generalize shedding patterns. Enhanced surveillance for studies of transmission of norovirus in hospital outbreaks has yielded a considerable number of faecal samples from symptomatic and asymptomatic shedders, both from patients and staff. Norovirus concentrations were determined by real-time PCR. A quantitative dynamic model was fitted to the shedding data, in a multilevel Bayesian framework, to study the time-course of shedding and its variation. The results indicate that shedding in asymptomatic subjects is similar to that in symptomatic infections, both showing considerable variation in peak levels (average 105-109 /g faeces) as well as duration of virus shedding (average 8-60 days). Patients appear to shed higher numbers of virus than staff, for slightly longer durations, but the differences are too small to be significant. Given equal shedding, the greater contribution of symptomatic cases to transmission must be caused by their higher efficiency in spreading these viruses. The results of this study will be helpful for risk studies that need to quantify the deposition of virus in the environment.

Citing Articles

Navigating Uncertainties in RT-qPCR and Infectivity Assessment of Norovirus.

Mirmahdi R, Dicker S, Yusuf N, Montazeri N Food Environ Virol. 2025; 17(1):22.

PMID: 40057626 PMC: 11890344. DOI: 10.1007/s12560-024-09632-0.


Norovirus-associated diarrhea and asymptomatic infection in children aged under 4 years: a community-cohort study in the Philippines.

Yu C, Corpuz M, Bonifacio J, Kishi M, Imamura T, Sayama Y IJID Reg. 2025; 14:100549.

PMID: 39877416 PMC: 11773203. DOI: 10.1016/j.ijregi.2024.100549.


Genomic characterization of noroviruses from an outbreak associated with oysters.

Flint A, Harlow J, McLeod M, Blondin-Brosseau M, Weedmark K, Nasheri N Microbiol Spectr. 2025; 13(2):e0258024.

PMID: 39792002 PMC: 11793256. DOI: 10.1128/spectrum.02580-24.


Membrane asymmetry facilitates murine norovirus entry and persistent enteric infection.

Stewart B, Pierce L, Olson M, Orchard R bioRxiv. 2024; .

PMID: 39574648 PMC: 11580941. DOI: 10.1101/2024.11.06.622376.


Traceback and Testing of Food Epidemiologically Linked to a Norovirus Outbreak at a Wedding Reception.

Papafragkou E, Kita-Yarbro A, Yang Z, Chhabra P, Davis T, Blackmore J J Food Prot. 2024; 88(1):100395.

PMID: 39505084 PMC: 11844314. DOI: 10.1016/j.jfp.2024.100395.


References
1.
Teunis P, Heijne J, Sukhrie F, van Eijkeren J, Koopmans M, Kretzschmar M . Infectious disease transmission as a forensic problem: who infected whom?. J R Soc Interface. 2013; 10(81):20120955. PMC: 3627102. DOI: 10.1098/rsif.2012.0955. View

2.
Atmar R, Opekun A, Gilger M, Estes M, Crawford S, Neill F . Norwalk virus shedding after experimental human infection. Emerg Infect Dis. 2008; 14(10):1553-7. PMC: 2609865. DOI: 10.3201/eid1410.080117. View

3.
Verhoef L, Vennema H, van Pelt W, Lees D, Boshuizen H, Henshilwood K . Use of norovirus genotype profiles to differentiate origins of foodborne outbreaks. Emerg Infect Dis. 2010; 16(4):617-24. PMC: 3321941. DOI: 10.3201/eid1604.090723. View

4.
Marks P, Vipond I, CARLISLE D, Deakin D, Fey R, Caul E . Evidence for airborne transmission of Norwalk-like virus (NLV) in a hotel restaurant. Epidemiol Infect. 2000; 124(3):481-7. PMC: 2810934. DOI: 10.1017/s0950268899003805. View

5.
Atmar R, Bernstein D, Harro C, Al-Ibrahim M, Chen W, Ferreira J . Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med. 2011; 365(23):2178-87. PMC: 3761795. DOI: 10.1056/NEJMoa1101245. View